U.S. IT Stock News

NYSE:IOT
NYSE:IOTSoftware

Samsara (IOT) Profitability Turn Challenges Cautious Narratives In Q1 2027 Earnings

Samsara (IOT) opened its Q1 2027 report with revenue of US$478.8 million and basic EPS of US$0.08, setting a clear marker for how the business is translating its top line into profit. The company reported revenue of US$366.9 million in Q1 2026 and US$478.8 million in Q1 2027, while basic EPS moved from a loss of US$0.04 in Q1 2026 to a profit of US$0.08 in the latest quarter. This puts margins and profitability firmly in focus for investors watching how this earnings profile develops. See our...
NasdaqGS:CSX
NasdaqGS:CSXTransportation

Is It Too Late To Consider CSX (CSX) After Strong 1 Year Share Price Run?

Wondering if CSX at around US$46.99 is still good value, or if most of the upside is already reflected in the price? This article walks through what the current valuation signals actually say. CSX's share price is at US$46.99, with returns of 3.8% over the last 7 days, 3.0% over 30 days, 29.6% year to date and 47.9% over 1 year. The 3 year and 5 year returns are 51.8% and 55.2% respectively. Recent news has centered on CSX's role in US transportation infrastructure and how rail capacity,...
NasdaqGS:VC
NasdaqGS:VCAuto Components

Is It Time To Reassess Visteon (VC) After Its 42% One Year Share Price Rally?

If you are wondering whether Visteon stock still offers value after a strong run, the key is to separate price excitement from underlying worth. The stock closed at US$117.46, with returns of 3.3% over the last 30 days and 21.2% year to date, while the 1 year return sits at 42.4% and the 3 and 5 year periods show declines of 20.3% and 6.4% respectively. Recent coverage of Visteon has focused on its role within the auto components sector and how the stock fits into broader market...
NasdaqGS:WLTH
NasdaqGS:WLTHCapital Markets

Wealthfront (WLTH) Valuation Check After Recent Share Price Volatility

Wealthfront (WLTH) has drawn fresh attention after recent trading, with the stock closing at US$9.85 and showing mixed performance, down over the past month yet higher over the past 3 months. See our latest analysis for Wealthfront. The recent 1 day share price return of down 14.35% and 7 day share price return of down 19.39% contrast with a 90 day share price return of 16.02%. This suggests fading short term momentum after a stronger quarter. If that shift in sentiment has you reassessing...
NYSE:MIAX
NYSE:MIAXCapital Markets

Assessing Miami International Holdings (MIAX) Valuation After Recent Share Price Weakness

Event driven overview of Miami International Holdings stock Miami International Holdings (MIAX) has drawn investor attention after recent share price pressure, with the stock down about 18% over the past month and roughly 4% over the past 3 months. See our latest analysis for Miami International Holdings. At a share price of $39.21, Miami International Holdings has seen short term pressure, with the 7 day share price return down 17.02% and the year to date share price return down 10.17%. This...
NYSE:NRGV
NYSE:NRGVElectrical

Energy Vault Expands Into Japan With 850 MW Storage Portfolio Shift

Energy Vault Holdings (NYSE:NRGV) agreed to acquire an 850 MW battery energy storage development portfolio in Japan from BayWa r.e. AG. The deal marks NRGV's entry into Japan, adding a large set of battery projects to its global pipeline. The portfolio consists of large scale battery energy storage system projects across key Japanese power markets. Energy Vault focuses on energy storage solutions that support grid reliability and renewable power integration. This move into Japan aligns with...
NYSE:ESRT
NYSE:ESRTOffice REITs

Is Empire State Realty Trust (ESRT) Pricing Reflect Recent Share Slump And Office REIT Concerns

If you are wondering whether Empire State Realty Trust at US$5.27 is a bargain or a value trap, the key is to look closely at what the current price actually implies. The stock has been under pressure, with the share price down 8.0% over the past week, 7.1% over the past month, 18.5% year to date, and 36.0% over the last year. These moves can change how investors think about both upside potential and risk. Recent coverage around office real estate and investor sentiment toward Office REITs...
NasdaqGS:SSNC
NasdaqGS:SSNCProfessional Services

Commerce Trust Genesis Launch Highlights SS&C Cloud AI Adoption Story

Commerce Trust has gone live on SS&C Advent’s Genesis platform, using SS&C Technologies Holdings’ cloud-native, AI-enabled system for integrated investment operations. The go-live adds to a reported group of more than 30 firms implementing Genesis since 2024. The move highlights growing interest in unified, modern investment management platforms that combine operations, data and analytics. For investors tracking SS&C Technologies Holdings (NasdaqGS:SSNC), the Commerce Trust launch puts...
NYSE:INGR
NYSE:INGRFood

Is Ingredion’s Benicaros Bet and Sanstar JV Reframing the Specialty Ingredients Case for INGR?

In late May 2026, Ingredion Incorporated announced a joint venture and 9% equity stake in India-based Sanstar Limited while also acquiring Benicaros, a patented prebiotic fiber made from upcycled carrot pomace, expanding its presence in pharmaceutical and specialty food ingredients and enhancing its health-focused product portfolio. These moves deepen Ingredion’s capabilities in clean-label, science-led specialty ingredients, combining local Indian manufacturing with proprietary...
NasdaqCM:NKTR
NasdaqCM:NKTRPharmaceuticals

A Look At Nektar Therapeutics (NKTR) Valuation After Recent Share Price Pullback

Nektar Therapeutics (NKTR) has drawn attention after recent trading saw the stock fall 3.4% in a day and 11.7% over the past week, prompting investors to reassess this US-based biopharmaceutical company. See our latest analysis for Nektar Therapeutics. While Nektar Therapeutics’ share price has fallen 11.7% over the past week and 32.6% over the past month, the year to date share price return of 32% and a very large 1 year total shareholder return suggest earlier momentum is now fading as...
NYSE:CWAN
NYSE:CWANSoftware

Clearwater Analytics Deepens AI Role In Core Institutional Workflows

Clearwater Analytics Holdings (NYSE:CWAN) has launched a new suite of AI-enabled investment data products for institutional investors. The offerings, branded as Clearwater Compass, Total Portfolio Oversight, and Fund Analytics, target operations, risk, and private market workflows. The new tools are designed to automate data handling, improve portfolio transparency, and extend coverage into private markets. Clearwater Analytics Holdings, which trades at $24.37 under ticker NYSE:CWAN, is...
NasdaqGM:WVE
NasdaqGM:WVEPharmaceuticals

Wave Life Sciences Faces Setback As WVE-007 Fails And Investor Exits

Wave Life Sciences' obesity candidate WVE-007 did not show meaningful improvement in recent clinical data. Following the data release, institutional investor Exome Asset Management exited its entire position in NasdaqGM:WVE. The setback affects Wave Life Sciences' obesity efforts and adds pressure to its broader development pipeline. For investors watching NasdaqGM:WVE, this update comes in the context of a share price of $5.73 and a year-to-date return that is down 64.1%. The stock has...
NYSE:MO
NYSE:MOTobacco

Is It Time To Reassess Altria Group (MO) After Its Strong Multi‑Year Share Price Gains

Wondering if Altria Group at around US$72.19 is offering fair value or an opening for better returns? This article walks through what the current price really reflects. The stock has returned 3.8% over the last week, 2.9% over the last month, 26.0% year to date, 30.4% over the past year, 101.8% over three years and 114.1% over five years, which gives important context before comparing price to underlying value. Recent coverage has focused on Altria Group's ongoing position in the tobacco...
NasdaqGS:OPK
NasdaqGS:OPKHealthcare

OPKO Deepens Nicoya Alliance As RAYALDEE China Prospects Draw Focus

OPKO Health (NasdaqGS:OPK) has expanded its alliance with Nicoya Therapeutics to advance the commercialization of RAYALDEE in Greater China. The amended agreement gives OPKO an equity interest in Nicoya Therapeutics and a deeper collaborative role in the partnership. The move focuses on driving regulatory progress and commercial preparation for RAYALDEE in a region with significant renal health needs. OPKO Health focuses on diagnostics and pharmaceuticals, with RAYALDEE positioned for...
NYSE:SSMR
NYSE:SSMRMetals and Mining

A Look At Sunshine Silver Mining & Refining (SSMR) Valuation After Its Sharp One Day Share Price Drop

Sunshine Silver Mining & Refining stock overview Sunshine Silver Mining & Refining (SSMR) drew investor attention after a sharp 18.4% one day share price decline to $14. This move has refocused interest on the company’s fundamentals and current valuation. See our latest analysis for Sunshine Silver Mining & Refining. The sharp 18.4% one-day share price decline comes after a period in which the year-to-date share price return is still 3.7%, so short-term momentum is fading even as the...
NasdaqGS:CCB
NasdaqGS:CCBBanks

A Look At Coastal Financial (CCB) Valuation After Fed Rate Decision And Banking As A Service Growth

What sparked the latest move in Coastal Financial? Coastal Financial (CCB) has been moving with the wider regional bank group after the Federal Reserve kept interest rates at 3.75%, while a resilient labor market shifted expectations for the timing of future cuts. See our latest analysis for Coastal Financial. At a share price of US$70.24, Coastal Financial has seen its 30 day share price return fall 6.28% and its year to date share price return fall 38.01%, while the 5 year total shareholder...
NasdaqGS:ZUMZ
NasdaqGS:ZUMZSpecialty Retail

Zumiez (ZUMZ) Q1 Loss Revives Concerns Around Thin Margins And Bullish Earnings Narratives

Zumiez (ZUMZ) opened Q1 2027 with revenue of US$193.3 million and a reported loss of US$13.3 million, or EPS of US$0.82, while trailing twelve month EPS sat at US$0.89. Over the past year, revenue on a trailing basis has moved from US$896.2 million to US$938.1 million, with TTM EPS lifting from US$0.04 to US$0.89 as margins shifted from very thin profitability to a modest 1.5% net margin that puts the latest quarter’s loss into a broader, improving earnings picture. See our full analysis for...
NasdaqGM:MVIS
NasdaqGM:MVISElectronic

A Look At MicroVision (MVIS) Valuation As A Reverse Stock Split Proposal Takes Center Stage

MicroVision (MVIS) has put a reverse stock split proposal at the center of its upcoming 2026 Annual Meeting, asking shareholders to authorize a split in a 1 for 5 to 1 for 15 range. See our latest analysis for MicroVision. The reverse stock split proposal comes after a sharp reset in MicroVision’s share price, which is down 56.11% on a year to date share price return basis and has delivered a 65.75% decline in total shareholder return over the past year. This points to fading momentum as the...
NYSE:AGX
NYSE:AGXConstruction

Argan (AGX) Earnings Growth And 15.5% Margin Test Bullish Backlog Narratives

Argan (AGX) has opened Q1 2027 with total revenue of US$291.0 million and basic EPS of US$3.30, against trailing twelve month revenue of US$1.0 billion and EPS of US$11.64 that came with 61.1% year over year earnings growth. Over the last year, the company has seen revenue move from US$874.2 million to US$1.0 billion on a trailing basis, while EPS stepped up from US$6.35 to US$11.64, pointing to a higher earnings contribution on each dollar of sales. With net margins running stronger than a...
NYSE:MPT
NYSE:MPTHealth Care REITs

Will Medical Properties Trust's Maintained Dividend Amid Heavy Short Interest Change Medical Properties Trust's (MPT) Narrative

Medical Properties Trust, Inc. previously announced that its Board of Directors declared a regular quarterly cash dividend of US$0.09 per share, payable on July 16, 2026, to shareholders of record as of June 18, 2026. This dividend affirmation comes as the company faces very large short interest, significant debt and negative earnings, keeping investor focus on its financial resilience. We’ll now examine how the combination of dividend maintenance and very large short interest may reshape...
NasdaqGS:QRVO
NasdaqGS:QRVOSemiconductor

Do Qorvo’s (QRVO) Margin Gains and Insider Sales Reveal a New Risk‑Reward Trade‑Off?

In recent weeks, Qorvo reported a fourth-quarter earnings beat with stronger adjusted margins, while CEO Robert Bruggeworth and Director Peter Feld collectively sold over US$198 million of stock under disclosed plans. Together, the earnings outperformance and sizable insider sales highlight a company improving operational efficiency even as senior leaders reduce their shareholdings. We’ll now explore how Qorvo’s stronger margins, despite handset headwinds, may influence the existing...
NasdaqGS:PONY
NasdaqGS:PONYSoftware

Pony AI Stock Connect Access Opens Mainland Flows And Liquidity Questions

Pony AI (NasdaqGS:PONY) has been added to the Shanghai Hong Kong Stock Connect program. This inclusion allows eligible Mainland Chinese investors to trade Pony AI’s Hong Kong listed shares directly. The move may widen Pony AI’s potential investor base and support trading liquidity in its stock. Pony AI focuses on autonomous driving technology, a sector that sits at the intersection of artificial intelligence, automotive manufacturing, and mobility services. Access to Stock Connect comes as...
NasdaqCM:BBCP
NasdaqCM:BBCPConstruction

Thin Q2 Net Margin At Concrete Pumping Holdings (BBCP) Tests Bullish Earnings Growth Narrative

Concrete Pumping Holdings (BBCP) has just posted Q2 2026 results, reporting revenue of US$106.8 million and basic EPS of US$0.04, alongside net income of US$2.1 million. The company’s quarterly revenue has moved from US$93.9 million in Q2 2025 to US$103.7 million in Q3 2025, US$108.8 million in Q4 2025, US$90.6 million in Q1 2026 and now US$106.8 million in Q2 2026. Over the same period, basic EPS has ranged from a loss of US$0.06 in Q1 2025 to US$0.10 in Q4 2025 before landing at US$0.04...
NYSE:SLG
NYSE:SLGOffice REITs

Is SL Green Realty (SLG) Fairly Priced After Recent Share Price Rebound?

SL Green Realty might be on your radar if you are asking whether the recent share price offers good value or if risks are already priced in. The stock last closed at US$47.83, with returns of 5.4% over the past week, 7.0% over the past month, 1.9% year to date, while being down 22.2% over the past year and 19.6% over the past five years, and up 111.2% over the past three years. Recent headlines around Office REITs and broader commercial real estate have kept attention on balance sheets,...